- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
Metaraminol is a cardiovascular drug used to treat low blood pressure. It is a sympathomimetic amine, meaning it stimulates the sympathetic nervous system, which increases heart rate and blood pressure. It is used to treat hypotension, shock, and other conditions caused by low blood pressure. Metaraminol is also used to treat symptoms of anaphylaxis, such as difficulty breathing and dizziness. It is available in both injectable and oral forms.
Metaraminol is used in a variety of medical settings, including emergency rooms, intensive care units, and operating rooms. It is also used in pre- and post-operative care, as well as in the treatment of sepsis and other conditions. Metaraminol is generally considered safe and effective when used as directed.
Some companies in the Metaraminol market include Pfizer, Novartis, Sanofi, and Merck. Show Less Read more